A meta-study finds "female Viagra" to have low-to-moderate benefits and side effects.
The Food and Drug Administration's approval of a pharmaceutical treatment for low sexual desire in women has launched a heated debate over the dangers and benefits of medicalizing sex.
An early look at a Pacific Standard story that's currently only available to subscribers.
Research suggests that the now-FDA-approved female libido-booster is—at least in part—a pharmaceutical ploy.